The study, published in The Journal of Vascular Access, examined the performance of the device at Wilhelmina Children’s Hospital.
The ivWatch is a continuous monitoring system developed by ivWatch LLC. Along with the monitoring, the device is also equipped with early detection capabilities and is used to detect IV infiltrations and extravasations.
A study published in The Journal of Vascular Access suggests that the device can detect these events earlier than clinicians are able, according to a new press release. The device was deployed at the Wilhemina Children’s Hospital in the Netherlands, where it was used in a 24-bed neonatal care unit.
The results of the study consistently showed the ivWatch detecting events before clinicians.
The device uses a predictive algorithm and near-infrared light to detect alterations in the tissue around an IV site. If a change is detected, the clinicians are immediately notified.